n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with s-methylisothiopseudouronium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gross, GJ; Hsu, AK; Patel, HH | 1 |
| Jiang, X; Nakajima, Y; Sato, S; Shi, E | 1 |
2 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and s-methylisothiopseudouronium
| Article | Year |
|---|---|
COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat.
Topics: Analysis of Variance; Animals; Benzamides; Blood Pressure; Cardiotonic Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Guanidines; Heart Rate; Ischemic Preconditioning, Myocardial; Isoenzymes; Isothiuronium; Male; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrobenzenes; Piperazines; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Sulfonamides | 2004 |
COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cardiotonic Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Disease Models, Animal; Heart; Ischemic Preconditioning, Myocardial; Isothiuronium; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Morphine; Myocardial Infarction; Myocardium; Nitric Oxide Synthase Type II; Nitrobenzenes; Sulfonamides; Up-Regulation | 2006 |